DELEAGE JEAN 4
4 · CORCEPT THERAPEUTICS INC · Filed Mar 26, 2008
Insider Transaction Report
Form 4
ALTA BIOPHARMA PARTNERS II LP
10% Owner
Transactions
- Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying) - Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund) - Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund) - Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Footnotes (3)
- [F1]These securities are held by Alta BioPharma Partners II, L.P. ("ABPII").
- [F2]Alta Partners II, Inc. ("APII") provides investment advisory services to ABPII and Alta Embarcadero BioPharma Partners II, LLC ("AEBPII" and, along with ABPII, the "Funds"). Jean Deleage, Alix Marduel and Farah Champsi (collectively, the "Principals") are managing directors of Alta BioPharma Management II, LLC ("ABMII"), which is the general partner of ABPII, and the managers of AEBPII. Ms. Marduel is a director of the Issuer and files separate Section 16 reports. The Principals may be deemed to share voting and investment power over the shares held by the Funds. Each of the Reporting Persons disclaims beneficial ownership of all such shares held by the Funds, except to the extent of his, her or its proportionate pecuniary interest therein.
- [F3]These securities are held by AEBPII.